ATE345807T1 - Cg8327 und srm in der regulation von energie- homeostase - Google Patents

Cg8327 und srm in der regulation von energie- homeostase

Info

Publication number
ATE345807T1
ATE345807T1 AT03743885T AT03743885T ATE345807T1 AT E345807 T1 ATE345807 T1 AT E345807T1 AT 03743885 T AT03743885 T AT 03743885T AT 03743885 T AT03743885 T AT 03743885T AT E345807 T1 ATE345807 T1 AT E345807T1
Authority
AT
Austria
Prior art keywords
energy homeostasis
srm
regulation
proteins
triglycerides
Prior art date
Application number
AT03743885T
Other languages
English (en)
Inventor
Karsten Eulenberg
Arnd Steuernagel
Thomas Haeder
Guenter Broenner
Original Assignee
Develogen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Develogen Ag filed Critical Develogen Ag
Application granted granted Critical
Publication of ATE345807T1 publication Critical patent/ATE345807T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT03743885T 2002-03-14 2003-03-14 Cg8327 und srm in der regulation von energie- homeostase ATE345807T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP02005882 2002-03-14
EP02006012 2002-03-15
EP02006271 2002-03-20
EP02006810 2002-03-25

Publications (1)

Publication Number Publication Date
ATE345807T1 true ATE345807T1 (de) 2006-12-15

Family

ID=27808686

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03743885T ATE345807T1 (de) 2002-03-14 2003-03-14 Cg8327 und srm in der regulation von energie- homeostase

Country Status (7)

Country Link
US (1) US20050119206A1 (de)
EP (1) EP1492553B1 (de)
JP (1) JP2005519947A (de)
AT (1) ATE345807T1 (de)
AU (1) AU2003227071A1 (de)
DE (1) DE60309850T2 (de)
WO (1) WO2003075945A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4292208B2 (ja) * 2003-10-15 2009-07-08 エフ．ホフマン−ラ ロシュ アーゲー 乳癌に対するマーカーとしてのタンパク質ｓｐｅｅの使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780512B1 (fr) * 1998-06-25 2003-10-17 Lipha Utilisation de recepteurs de la famille rev-erb pour le criblage de substances utiles dans le traitement des dysfonctionnements du metabolisme lipidique
AU5243299A (en) * 1998-07-29 2000-02-21 Tularik Inc. Uncoupling protein-2(hcp2): compositions and methods of use
CA2384089A1 (en) * 1999-09-08 2001-03-15 Genentech, Inc. Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity
CA2399921A1 (en) * 2000-03-03 2001-09-13 Human Genome Sciences, Inc. Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
AU2001285743A1 (en) * 2000-06-16 2001-12-24 Develogen Ag Adipose-related gene
US20020048581A1 (en) * 2000-07-18 2002-04-25 King George L. Modulation of nitric oxide synthase by PKC
DE10037759A1 (de) * 2000-08-03 2002-07-04 Gruenenthal Gmbh Screeningverfahren
IL156405A0 (en) * 2000-12-12 2004-01-04 Quark Biotech Inc Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation

Also Published As

Publication number Publication date
EP1492553A2 (de) 2005-01-05
WO2003075945A2 (en) 2003-09-18
WO2003075945A3 (en) 2004-10-14
AU2003227071A1 (en) 2003-09-22
EP1492553B1 (de) 2006-11-22
DE60309850T2 (de) 2007-07-05
US20050119206A1 (en) 2005-06-02
JP2005519947A (ja) 2005-07-07
DE60309850D1 (de) 2007-01-04
AU2003227071A8 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
NO20060424L (no) 5-heteroringbaserte P38 kinaseinhibitorer
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
PL1615952T3 (pl) Sposoby leczenia chorób zapalnych z zastosowaniem środków specyficznie wiążących ludzką angiopoetynę-2
ATE545422T1 (de) Beta-glycolipide als immunomodulatoren
NO20073574L (no) Triazolsubstituerte aminobenzofenonforbindelser
NO20060781L (no) Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser
EA200501865A1 (ru) Аналоги тиовольфраматов и их применение
ATE345807T1 (de) Cg8327 und srm in der regulation von energie- homeostase
WO2003066086A3 (en) Proteins involved in the regulation of energy homeostatis
ATE545428T1 (de) Pik4cb involviert in der regulierung des energiestoffwechsels
NO20033541L (no) Anvendelse av fosfodiesteraseinhibitorer av type 4 ved hjertemuskelsykdommer
WO2003074078A3 (en) Cg3842 homologous proteins involved in the regulation of energy homeostasis
WO2004035082A3 (en) Proteins involved in the regulation of energy homeostasis
WO2004050007A3 (en) Mammalian bt-42 proteins involved in the regulation of energy homeostasis
WO2003103704A3 (en) PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS
WO2003092715A3 (en) Proteins involved in the regulation of energy homeostasis
WO2004020465A3 (en) Proteins involved in the regulation of energy homeostasis
WO2004016641A3 (en) Proteins involved in the regulation of energy homeostasis
WO2004047855A3 (en) Proteins involved in the regulation of energy homeostasis
WO2004064856A3 (en) Proteins involved in the regulation of energy homeostasis
WO2004002513A3 (en) Proteins involved in the regulation of energy homeostasis
WO2003084566A3 (en) Proteins involved in the regulation of energy homeostasis
NO20062316L (no) Nye CXCL8 antagonister
WO2003066087A3 (en) Kinases involved in the regulation of energy homeostasis
ATE476185T1 (de) Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties